CORBUS PHARMACEUTICALS HOLDINGS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • January 5th, 2018 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 5th, 2018 Company Industry JurisdictionCorbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: